Gene: IPO4
Official Full Name: importin 4provided by HGNC
Gene Summary: Enables nuclear import signal receptor activity and nuclear localization sequence binding activity. Involved in protein import into nucleus. Located in chromatin. Part of protein-containing complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO03349 | IPO4 Knockout cell line (HeLa) | Human | IPO4 | 1:3~1:6 | Negative | Online Inquiry |
KO03350 | IPO4 Knockout cell line (HCT 116) | Human | IPO4 | 1:2~1:4 | Negative | Online Inquiry |
KO03351 | IPO4 Knockout cell line (HEK293) | Human | IPO4 | 1:3~1:6 | Negative | Online Inquiry |
KO03352 | IPO4 Knockout cell line (A549) | Human | IPO4 | 1:3~1:4 | Negative | Online Inquiry |
IPO4 Gene Knockout Cell Lines are genetically engineered cell lines that have been specifically designed to have a targeted disruption of the IPO4 gene. This gene is known to encode importin-4, a member of the importin family of proteins that facilitate the nuclear transport of various macromolecules, including RNA and proteins. By creating these knockout models, researchers can investigate the role of IPO4 in cellular processes, such as gene expression regulation and cellular signaling pathways.
The primary function of these cell lines is to enable scientists to explore the implications of IPO4 deficiency on cellular behavior and to elucidate the molecular mechanisms associated with nuclear transport. The knockout of IPO4 leads to an altered transport process, providing insight into how the absence of this protein affects nuclear localization signals (NLS) and potentially disrupts cellular homeostasis and phenotype. Through various methodologies such as Western blotting, flow cytometry, and gene expression profiling, users can assess the phenotypic alterations and signaling defects arising from the loss of IPO4 function.
The scientific significance of IPO4 Gene Knockout Cell Lines extends to both basic research and clinical applications. In research, these cell lines are invaluable for studying nuclear transport mechanisms, and their implications in diseases such as cancer and neurodegenerative disorders. Clinically, they can aid in drug discovery and the development of targeted therapies that modulate the nuclear transport pathways influenced by IPO4.
What sets our IPO4 Gene Knockout Cell Lines apart from alternative products on the market is our precise gene editing technology, which ensures high specificity and efficiency in gene knockout. Additionally, our cell lines are thoroughly characterized, providing researchers with reliable models that reduce variability in experiments.
For researchers and clinicians, the value of these cell lines lies in their ability to deliver critical insights into the role of nuclear transport in health and disease. By using our IPO4 Gene Knockout Cell Lines in their studies, users can advance their research efforts with confidence, backed by our commitment to quality and innovation. With years of expertise in genetic engineering and cell line development, our company stands ready to support the scientific community with cutting-edge tools and solutions.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.